Trials / Completed
CompletedNCT02954705
MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS
MICRO-RNAs OF NEUTROPHILS IN RENAL ANCA-ASSOCIATED VASCULITIS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Activation of neutrophils by ANCA ("Anti-Neutrophil Cytoplasm Antibodies") and subsequent microvascular endothelial cell damage is the main feature of ANCA-associated vasculitis (AAV), a severe autoimmune disease that often targets the kidney. There is no specific treatment for AAV to date and 25% of patients with renal damage evolve towards end-stage renal disease, requiring dialysis and kidney transplantation. In addition, there is no reliable biological marker of the disease activity available, which makes the diagnostic, follow-up and treatment of patients difficult. Therefore, the identification of new therapeutic targets and non-invasive biomarkers constitutes a major clinical challenge to improve AAV patients care and to ameliorate their renal outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non interventional study | This is a non interventional study because all levies are performed during visit planned for the care of patients. |
Timeline
- Start date
- 2017-08-28
- Primary completion
- 2019-12-31
- Completion
- 2020-09-30
- First posted
- 2016-11-03
- Last updated
- 2020-10-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02954705. Inclusion in this directory is not an endorsement.